Clinical Trials Sponsored by Cancer Institute of New Jersey

Total 15428 results

Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Bayer; Novartis Pharmaceuticals; Rutgers Cancer...

Completed

Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer

Metastatic Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
Robert Wood Johnson Foundation; Rutgers Cancer Institute of New Jersey

Completed

Combination Medications vs. Patch Alone for Medically-Ill Smokers

Smoking Cessation

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Merck Sharp & Dohme LLC; Rutgers Cancer Institute...

Active, not recruiting

Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer

Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey; Biosuccess...

Terminated

Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies

Leukemia

United States
University of Colorado, Denver
Rutgers Cancer Institute of New Jersey

Terminated

Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection

Bladder Carcinoma

United States
Elisa Kallioniemi

Not yet recruiting

Developing and Optimizing Transcranial Magnetic Stimulation for Motor Rehabilitation

Motor Skills | Motor Cortex
National Cancer Institute (NCI)
Rutgers Cancer Institute of New Jersey

Completed

Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG

Bladder Cancer

United States
Rutgers, The State University of New Jersey
Rutgers Cancer Institute of New Jersey; Elekta Limited; Cianna Medical, Inc.

Completed

Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery (TRIUMPH-T)

Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Ductal Breast Carcinoma In Situ

United States
Rutgers, The State University of New Jersey
New Jersey Health Foundation

Not yet recruiting

Twin Block, Pain Medications and Third Molar Extractions

Acute Pain

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Withdrawn

Collecting and Storing Blood Samples From Patients With Cancer

Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Nonmalignant Neoplasm | Lymphoproliferative Disorder and other conditions
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation

Lymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease

Lymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Dextromethorphan in Treating Patients With Fatigue Caused by Cancer

Unspecified Childhood Solid Tumor, Protocol Specific | Fatigue | Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Precancerous/Nonmalignant Condition

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Melanoma (Skin)

United States
Rutgers, The State University of New Jersey
New Jersey Medical School

Terminated

Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache

Postdural Puncture Headache

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer

Prostate Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer

Lung Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Withdrawn

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditions

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Withdrawn

Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin

Carcinoma of Unknown Primary

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer

Cervical Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer

Prostate Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Sulindac and Plant Compounds in Preventing Colon Cancer

Colorectal Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Kidney Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Prostate Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

Prostate Cancer | Osteoporosis

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Internet Use Among Women With Recurrent Metastatic Breast Cancer

Breast Cancer

United States
Christian Hinrichs
National Cancer Institute (NCI); Cancer Immunology and Metabolism Center of...

Recruiting

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

Cervical Cancer | Breast Cancer | Gastric Cancer | Lung Cancer

United States
Psoriasis Treatment Center of Central New Jersey

Unknown

An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients

Psoriasis

United States
Psoriasis Treatment Center of Central New Jersey

Completed

Combination of Sotyktu and Enstilar for Plaque Psoriasis

Psoriasis

United States
Psoriasis Treatment Center of Central New Jersey

Completed

Vtama in Psoriasis Patients Being Treated With Biologics.

Psoriasis

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Sanofi

Withdrawn

Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia

Hyperglycemia | Leukemia

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); The Cancer Registry of Greater California; The...

Recruiting

Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial

Head and Neck Cancer | Oral Cancer | Oropharyngeal Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Aventis Pharmaceuticals

Terminated

Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Recruiting

Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings

Diabetes Mellitus, Type 2 | Colorectal Cancer Screening

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Recruiting

MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors

Melanoma

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Recruiting

Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families

Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Clinical Stage 0 Cutaneous Melanoma AJCC v8 | Clinical Stage I Cutaneous Melanoma AJCC v8 | Clinical Stage IA Cutaneous Melanoma AJCC v8 | Clinical... and other conditions

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Active, not recruiting

Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin

Metastatic Skin Squamous Cell Carcinoma | Recurrent Skin Squamous Cell Carcinoma | Locally Advanced Skin Squamous Cell Carcinoma

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Terminated

Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Prostate Cancer

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Completed

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Lymphoma | Metastatic Melanoma | Metastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage III Bladder Cancer | Stage IV Bladder Cancer | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm and other conditions

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Active, not recruiting

Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Oropharyngeal Human Papillomavirus-Positive Squamous...

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Terminated

Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer

Pancreatic Cancer | Malnutrition | Lung Cancer | Prostate Cancer | Weight Changes

United States

Clinical Trials Sponsored by Cancer Institute of New Jersey

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations